“…In cardiac surgical patients, Iribarren and colleagues 22 showed that the patients who received etomidate required a higher dose of vasopressors during the postoperative period than those who received other induction agents, whilst other studies found no difference in vasopressor requirement 20 and outcomes, including mechanical ventilation time and length of ICU and hospital stay, between etomidate and other induction agents. 21,23,24 In non-cardiac surgery, one study demonstrated no differences in intraoperative haemodynamic parameters, vasopressor requirement, 19 and length of hospital stay between etomidate and propofol, although our previous work showed an increased incidence of postoperative cardiovascular morbidities. 5 Information regarding the effect of corticosteroid supplementation after etomidate exposure in an elective surgical population is scarce.…”